New drug could curb binge eating episodes
NCT ID NCT06413433
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial is testing whether solriamfetol, a drug already approved for sleep disorders, can reduce binge eating episodes in adults with binge eating disorder. About 450 participants will receive either solriamfetol or a placebo daily for 12 weeks. The main goal is to see if the drug decreases the number of binge episodes compared to placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Solriamfetol
What this could lead to
If successful, this could provide a new medication option to help reduce binge eating episodes in adults with binge eating disorder.
What could go wrong
This is a Phase 3 trial, but results may not show a meaningful benefit over placebo. Side effects or lack of long-term data could limit its use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BINGE EATING DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Site
RECRUITINGEncino, California, 91316, United States
-
Clinical Research Site
RECRUITINGGarden Grove, California, 92845, United States
-
Clinical Research Site
RECRUITINGLong Beach, California, 90806, United States
-
Clinical Research Site
RECRUITINGNewport Beach, California, 92660, United States
-
Clinical Research Site
TERMINATEDSan Diego, California, 92103, United States
-
Clinical Research Site
RECRUITINGSanta Ana, California, 92705, United States
-
Clinical Research Site
RECRUITINGWalnut Creek, California, 94596, United States
-
Clinical Research Site
RECRUITINGWest Covina, California, 91790, United States
-
Clinical Research Site
RECRUITINGColorado Springs, Colorado, 80910, United States
-
Clinical Research Site
RECRUITINGCromwell, Connecticut, 06416, United States
-
Clinical Research Site
TERMINATEDClermont, Florida, 34711, United States
-
Clinical Research Site
RECRUITINGFort Myers, Florida, 33912, United States
-
Clinical Research Site
RECRUITINGHialeah, Florida, 33012, United States
-
Clinical Research Site
RECRUITINGJacksonville, Florida, 32256, United States
-
Clinical Research Site
RECRUITINGLauderhill, Florida, 33319, United States
-
Clinical Research Site
RECRUITINGMiami, Florida, 33145, United States
-
Clinical Research Site
RECRUITINGMiami, Florida, 33176, United States
-
Clinical Research Site
TERMINATEDMiami Lakes, Florida, 33016, United States
-
Clinical Research Site
RECRUITINGOrlando, Florida, 32801, United States
-
Clinical Research Site
TERMINATEDOrlando, Florida, 32806, United States
-
Clinical Research Site
RECRUITINGMarietta, Georgia, 30060, United States
-
Clinical Research Site
RECRUITINGOverland Park, Kansas, 66210, United States
-
Clinical Research Site
RECRUITINGBoston, Massachusetts, 02131, United States
-
Clinical Research Site
TERMINATEDMethuen, Massachusetts, 01844, United States
-
Clinical Research Site
RECRUITINGSaint Charles, Missouri, 63304, United States
-
Clinical Research Site
RECRUITINGCherry Hill, New Jersey, 08002, United States
-
Clinical Research Site
RECRUITINGPrinceton, New Jersey, 08540, United States
-
Clinical Research Site
RECRUITINGMount Kisco, New York, 10549, United States
-
Clinical Research Site
RECRUITINGNew York, New York, 10128, United States
-
Clinical Research Site
RECRUITINGRaleigh, North Carolina, 27607, United States
-
Clinical Research Site
RECRUITINGCincinnati, Ohio, 45215, United States
-
Clinical Research Site
RECRUITINGMason, Ohio, 45040, United States
-
Clinical Research Site
RECRUITINGMiddleburg Heights, Ohio, 44130, United States
-
Clinical Research Site
TERMINATEDNorth Canton, Ohio, 44720, United States
-
Clinical Research Site
RECRUITINGPortland, Oregon, 97210, United States
-
Clinical Research Site
RECRUITINGAllentown, Pennsylvania, 18104, United States
-
Clinical Research Site
RECRUITINGMedia, Pennsylvania, 19063, United States
-
Clinical Research Site
RECRUITINGGreenville, South Carolina, 29615, United States
-
Clinical Research Site
RECRUITINGNorth Charleston, South Carolina, 29405, United States
-
Clinical Research Site
RECRUITINGMemphis, Tennessee, 38119, United States
-
Clinical Research Site
RECRUITINGAustin, Texas, 73787, United States
-
Clinical Research Site
RECRUITINGAustin, Texas, 78731, United States
-
Clinical Research Site
RECRUITINGDallas, Texas, 75231, United States
-
Clinical Research Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Clinical Research Site
TERMINATEDDraper, Utah, 84020, United States